228 related articles for article (PubMed ID: 22323747)
1. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Zesiewicz TA; Greenstein PE; Sullivan KL; Wecker L; Miller A; Jahan I; Chen R; Perlman SL
Neurology; 2012 Feb; 78(8):545-50. PubMed ID: 22323747
[TBL] [Abstract][Full Text] [Related]
2. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
[TBL] [Abstract][Full Text] [Related]
4. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
6. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
7. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
[TBL] [Abstract][Full Text] [Related]
8. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
9. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nicotine dependence with Chantix (varenicline).
Rankin KV; Jones DL
Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
[TBL] [Abstract][Full Text] [Related]
11. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
Tonstad S; Davies S; Flammer M; Russ C; Hughes J
Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
[TBL] [Abstract][Full Text] [Related]
13. Varenicline in smoking cessation.
Tonstad S; Rollema H
Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
[TBL] [Abstract][Full Text] [Related]
14. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
[TBL] [Abstract][Full Text] [Related]
15. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
[TBL] [Abstract][Full Text] [Related]
16. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F
Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Filla A; Sacca F; De Michele G
Neurology; 2012 May; 78(19):1538. PubMed ID: 22565570
[No Abstract] [Full Text] [Related]
18. A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3.
Connolly BS; Prashanth LK; Shah BB; Marras C; Lang AE
Neurology; 2012 Nov; 79(22):2218. PubMed ID: 23183282
[No Abstract] [Full Text] [Related]
19. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
[TBL] [Abstract][Full Text] [Related]
20. [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study].
Fagerström KO; Gilljam H; Tonstad S
Lakartidningen; 2011 Nov 2-8; 108(44):2215-7. PubMed ID: 22165180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
